News and Events for Attorneys and Executives

Antitrust

Antitrust Lawyers Leiv Blad and Zarema Jaramillo Join Lowenstein in D.C. Office

News
Lowenstein Sandler LLP announced that Leiv Blad has joined the firm as a partner and co-chair of the firm’s antitrust practice in Washington, D.C. Blad joins with Zarema Jaramillo, who becomes senior counsel in the firm’s antitrust practice.

Continue Reading »

How a Typical Tolling Agreement Cost Duke Energy Corporation $600,000

How a Typical  Tolling Agreement Cost Duke Energy Corporation $600,000

Insight
A court recent ruled that a tolling agreement, when entered into between companies that intended to merge, violated the Hart-Scott-Rodino Antitrust Improvements Act of 1976, leading to the imposition of significant financial penalties against the buyer, according to Hogan Lovells.

Continue Reading »

Judge Blocks $54 Billion Anthem-Cigna Health Insurance Merger

News
A federal judge blocked the $54 billion merger between health insurance giants Anthem and Cigna, saying the deal would increase prices and reduce competition, according to a report by The Washington Post.

Continue Reading »

Event – A Wake-Up Call: Antitrust Compliance in the U.S.

Event – A Wake-Up Call: Antitrust Compliance in the U.S.

Event, Jan. 19, NYC
Bloomberg BNA will present a complimentary event to discuss the widespread corporate apathy towards antitrust risks – and why the business community needs a collective wake-up call.

Continue Reading »

Lex Machina Expands Legal Analytics Platform to Cover Antitrust Litigation

News
The new module enables attorneys to make data-driven decisions about federal antitrust case strategies and tactics and gives lawyers a competitive advantage in antitrust litigation

Continue Reading »

U.S. Sues to Block Anthem-Cigna and Aetna-Humana Mergers

U.S. Sues to Block Anthem-Cigna and Aetna-Humana Mergers

News
U.S. Attorney General Loretta E. Lynch said the proposed mergers “would leave much of the multitrillion-dollar health insurance industry in the hands of three mammoth insurance companies,” reports The New York Times.

Continue Reading »

Governance Challenges 2016: M&A Oversight

Governance Challenges 2016: M&A Oversight

White Paper
The NACD report addresses the importance of early board engagement in strategy, the need for proactive dialogue with all key stakeholders, and the imperative to balance short-term and long-term goals throughout the M&A process.

Continue Reading »

Reverse Break-Up Fees and Specific Performance: A Survey of Remedies

White Paper
Thomson Reuters is offering a complimentary copy of the 2016 edition of Practical Law’s study, Reverse Break-Up Fees and Specific Performance: A Survey of Remedies for Financing and Antitrust Failure.

Continue Reading »

When Customer Supply Contracts Lead to Trouble

Article
Melanie A. Hallas of McDermott Will & Emery writes that a recent consent order shows that exclusivity terms that arguably have the effect of harming competition may raise antitrust concerns.

Continue Reading »

Justice Scalia’s Death Prompts Dow Chemical to Settle Price-Fixing Case

NEWS
Dow was facing a $1.1 billion judgment in a price-fixing case, but now Dow Chemical says it no longer thinks it could win its appeal without Justice Antonin Scalia on the bench.

Continue Reading »

Quarles and Brady Partner Andre Fiebig Publishes Two Books

Quarles and Brady Partner Andre Fiebig Publishes Two Books

NEWS
Andre Fiebig, a partner at Quarles & Brady, authored two books on antitrust law issues for Thomson Reuters and the American Bar Association.

Continue Reading »

High Court Allows State Law Antitrust Claims to Proceed Against Interstate Pipelines

High Court Allows State Law Antitrust Claims to Proceed Against Interstate Pipelines

White Paper
The court considered whether the Natural Gas Act pre-empts state law antitrust claims when the challenged conduct affects both federally regulated wholesale natural gas prices and non-federally regulated retail natural gas prices, reports Mintz, Levin.

Continue Reading »

Drug Maker Accused of Price Gouging

Drug Maker Accused of Price Gouging

NEWS
A lawsuit alleges Gilead Sciences is price gouging by pricing its Sovaldi hepatitis C treatment at $1,000 a pill, the Wall Street Journal reports in one of its blogs.

Continue Reading »

Antitrust Treatment of Physician Practice Acquisitions

Antitrust Treatment of Physician Practice Acquisitions

On-Demand
Practical Law has posted a discussion of the first cases to address the antitrust implications of hospital acquisitions of physician practices.

Continue Reading »

Qualcomm Faces Two New Antitrust Probes

Qualcomm Faces Two New Antitrust Probes

NEWS
Qualcomm faces three investigations into allegations of anti-competitive behaviour, as it revealed new probes in the US and EU on top of the antitrust inquiry it already faces in China, according to a report in The Financial Times.

Continue Reading »

Apple Facing Trial for Music Downloading Restrictions

Apple Facing Trial for Music Downloading Restrictions

NEWS
Apple will try to defend against allegations that it violated antitrust laws by trying to restrict music downloads for iPods to its iTunes store. Jury selection in the federal trial will begin Nov. 19, reports the San Jose Mercury News.

Continue Reading »

Hot Topics in Antitrust Compliance and Enforcement

Hot Topics in Antitrust Compliance and Enforcement

On-Demand
Baker & McKenzie presents a free on-demand webinar on how companies can address antitrust issues and enforcement in their compliance programs.

Continue Reading »

Top